Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Odactra Market Size And Revenue Outlook Through 2030
The historical growth can be linked to the rising occurrence of allergic rhinitis, enhanced understanding of immunotherapy advantages, the broadening reach of allergy specialist practices, the widespread availability of sublingual immunotherapy treatments, and more effective diagnosis of dust mite allergies.
The anticipated expansion during the projected period stems from the wider embrace of proactive allergy management, the broadening of treatment options for younger demographics with allergies, an increasing call for easily managed at-home therapies, a greater attention on fostering immune tolerance, and persistent development in biologics leveraging allergens.
Prominent tendencies for the upcoming period involve the growing acceptance of allergen immunotherapy in tablet form, a heightened emphasis on enduring, disease-altering allergy interventions, the broadening of at-home allergy management strategies, an increasing preference for immunotherapy alternatives not involving injections, and strengthened programs for patient compliance.
Get A Free Sample Report With In-Depth Market Insights:
Odactra Market Growth Factors Behind Sustained Expansion
The increasing prevalence of allergic diseases is anticipated to spur the growth of the odactra market. Allergic conditions stem from an abnormal immune response to typically harmless allergens, with their rise being linked to environmental shifts, greater exposure to allergens, urbanization, and changes in lifestyle and diet. Odactra employs allergen-specific immunotherapy, gradually exposing the body to dust mite allergens to desensitize the immune system, thereby mitigating allergic reactions, easing symptoms, and providing long-term relief for individuals with dust mite allergies. As an illustration, in April 2024, Allergy UK, a charity supporting allergy sufferers in the United Kingdom, reported that over five million people require specialized care for severe allergies, and projections indicate that by 2026, at least one in two Europeans will suffer from allergies. Consequently, the growing incidence of allergic diseases is fueling the expansion of the odactra market. The expanding number of hospitals is projected to stimulate the future growth of the odactra market. Hospitals are healthcare facilities that offer treatment and care for patients with illnesses or injuries, encompassing emergency services, surgery, and specialized medical attention. The increase in hospitals is driven by rising healthcare demands, population expansion, advancements in medical technology, and heightened investment in healthcare infrastructure. A greater availability of healthcare facilities, such as hospitals, will enhance patient access to allergy treatments. Specifically, the proliferation of hospitals providing specialized services, including immunotherapy for dust mite-induced allergic rhinitis, will boost the demand for medications like Odactra. For example, in May 2023, data from the American Health Care Association, a US-based nonprofit, showed that the United States had 6,129 hospitals in 2023, marking a 0.591% increase from 6,093 hospitals in 2022. Thus, the growing count of hospitals is contributing to the growth of the odactra market.
Odactra Market Segment Analysis: What Are The Core Market Categories?
The odactra market covered in this report is segmented –
1) By Indication: House Dust Mite-Induced Allergic Rhinitis, Allergic Conjunctivitis
2) By Age Group: Adults (18-65 Years), Adolescents (12-17 Years), Children (5-11 Years)
3) By Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospital Pharmacies
Odactra Market Industry Trends Fueling Future Revenue Growth
Leading companies in the odactra market are concentrating on creating novel solutions, including sophisticated sublingual allergy immunotherapy tablets. This effort addresses the growing need for better patient adherence, less invasive treatments, and sustained management of conditions triggered by allergens. These tablets administer precise amounts of particular allergens orally, progressively desensitizing the immune system, offering a more accessible and user-friendly option compared to conventional allergy injections, which necessitate regular visits to a clinic. As an example, in January 2023, ALK-Abelló, a pharmaceutical firm based in Denmark specializing in research, declared the U.S. Food and Drug Administration (FDA)’s approval of ODACTRA (House Dust Mite Allergen Extract) tablets for sublingual administration in adolescents between the ages of 12–17. This broadened approval permits ODACTRA to address allergic rhinitis caused by house dust mites, either with or without concurrent conjunctivitis, in patients ranging from 12–65 years old. ODACTRA functions as an immunotherapy for established HDM allergies, although it is not designed to offer immediate alleviation of symptoms.
Odactra Market Top Companies Driving Competitive Growth
Major companies operating in the odactra market are ALK Abello A/s
View The Full Odactra Market Report:
Odactra Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the odactra market in 2025. The regions covered in the odactra market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model